SAFB2 and neoplasm: Of particular note, CNV analysis of the three key prognostic genes in the Sscore model revealed that the deletion frequency of SAFB2 was substantially higher in High-Sscore patients, suggesting that loss of SAFB2 may contribute to tumor progression (Figures 5F, G).